+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Paclitaxel"

From
Ovarian Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Ovarian Cancer Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Bulk Paclitaxel - Global Strategic Business Report - Product Thumbnail Image

Bulk Paclitaxel - Global Strategic Business Report

  • Report
  • March 2025
  • 184 Pages
  • Global
From
Paclitaxel Injection Market Report 2025 - Product Thumbnail Image

Paclitaxel Injection Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Ovarian Cancer Drugs Market Report 2025 - Product Thumbnail Image

Ovarian Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
Advanced ovarian cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced ovarian cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 210 Pages
  • Global
From
Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 100 Pages
  • Global
From
Brain Metastasis from Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Metastasis from Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Ovarian Cancer Pipeline Analysis Report - Product Thumbnail Image

Ovarian Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Breast Cancer Pipeline Analysis Report - Product Thumbnail Image

Breast Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

Paclitaxel is a chemotherapy drug used to treat breast cancer. It is a semi-synthetic derivative of the natural product Taxol, which is extracted from the bark of the Pacific yew tree. Paclitaxel works by interfering with the normal process of cell division, preventing cancer cells from dividing and growing. It is typically used in combination with other drugs, such as doxorubicin, to treat advanced stages of breast cancer. Paclitaxel is available in both intravenous and oral formulations, and is often used in combination with other drugs to treat metastatic breast cancer. It is also used to treat other types of cancer, such as ovarian and lung cancer. Paclitaxel is marketed by several pharmaceutical companies, including Bristol-Myers Squibb, Pfizer, and Sanofi. It is also available as a generic drug in some countries. Companies in the Paclitaxel market include Bristol-Myers Squibb, Pfizer, Sanofi, Mylan, Teva Pharmaceuticals, and Apotex. Show Less Read more